Why it matters
Without AI planning, decisions risk solvent exposure, irreversible interactions, and delays in loan or shipment due to missing or conflicting documentation and uncertain protection efficacy.
From design to safety
Design
AI guides treatment proposal
AI analyzes material data, reversibility requirements, climate and odor thresholds, and substrate compatibility to propose facing tissue, cyclododecane containment, BEVA facing film, and temporary consolidation methods; it generates a provisional bill of materials, cross-references PACR standards, and sets documentation templates.
- facing tissue
- cyclododecane containment
- BEVA facing film
- temporary consolidation adhesives
Build
AI supports bench setup
The system validates chosen materials against project condition reports, PACR standards, and supplier data sheets, inventories required solvents, removals, and transport packaging, and prints bench-ready instructions with safety and COSHH notes.
- facing tissue
- cyclododecane containment
- transport crating system
- removal solvent kit
Operation
AI monitors during treatment
Real-time readings from moisture, solvent vapors, and temperature sensors are integrated with reference condition records; AI flags deviations, adjusts exposure windows, updates treatment progress, and records versioned notes to ensure traceability.
- BEVA facing film
- facing tissue
- temporary consolidation resin
- removal solvent kit
Maintenance
AI calibrates materials workflow
Regular checks compare material stock, shelf life, lot numbers, and prior treatment outcomes against predefined standards; prompts restock orders, recalls expired stock, and generates updated treatment proposals with confidence levels.
- transport crating system
- cyclododecane containment
- facing tissue
- BEVA facing film
Safety
AI enforces safety protocols
The system enforces COSHH, records safety checks, flags hazardous interactions, and routes approvals to the accredited conservator before any on-site handling; It documents PPE usage, ventilation status, and emergency stop sequences.
- temporary consolidation resin
- removal solvent kit
- facing tissue
- cyclododecane containment
Part by part
- 1
facing tissue
- Watch for
- Tearing, abrasion, or loss of surface fibers during handling or mounting.
- AI action
- Detect tearing risk from surface imaging and trigger conservator review.
- 2
cyclododecane containment
- Watch for
- Vapor concentration exceeding safe thresholds during application or evaporation.
- AI action
- Read gas sensor data and trigger ventilation or process pause.
- 3
BEVA facing film
- Watch for
- Incompatibility with substrate or previous coatings causing whitening or detachment.
- AI action
- Cross-check substrate data and initiate compatibility alert.
- 4
temporary consolidation adhesive
- Watch for
- Excessive penetration or uneven application compromising reversibility.
- AI action
- Analyze application pattern and adjust technique or material choice.
- 5
removal solvent kit
- Watch for
- Solvent residue risk on delicate substrates or interactions with facing tissue.
- AI action
- Flag residue risk and schedule controlled removal sequence.
- 6
transport crating system
- Watch for
- Inadequate protection during transport risking detachment or abrasion.
- AI action
- Evaluate crate integrity and sequence of transport events.
Worked example
Catching a tissue-induced collapse before a shipment
Illustrative scenario with sample data.
A boxed sculpture with fragile organic tissue requires temporary protection during transport and surface facing.
Signal in
materialData: {substrate:'polymer resin', facing:'tissue', conservant:'Paraloid B-72', cyclododecane:'present', BEVA:'BEVA 339', tissueAdhesive:'PVA-S'}; sensors:{temp:22, humidity:45, VOC:12, surfaceMoisture:7}; treatmentPlan:{facing:'BEVA film', tempConsolidation:'paraloid', removal:'ethanol', transport:'custom wooden crate with silica gel'}
System out
AI-generated plan approves BEVA facing, cyclododecane temporary protection, phased consolidation, and a stepwise transport protocol; creates transport, treatment, and condition records; flags potential solvent interactions for conservator review; generates a revised BOM and risk register.
Human sign-off: Head of conservation signs off on the plan, authorizes bench and transport procedures, and approves the associated condition report and insurance rider alignment.
How to roll it out
Phase 1
Weeks 1 to 2
Baseline data capture, stock checks, and AI rule calibration with PACR-compliant records.
Phase 2
Weeks 3 to 6
Prototype runs on three case studies, with documented feedback loops to refine warnings and decision thresholds.
Phase 3
Weeks 7 to 10
Full integration with condition reporting and treatment proposal workflows for on-site and off-site work, including disaster recovery tests.
Where people stay in charge
- All COSHH and solvent handling decisions remain with the accredited conservator or designated safety officer.
- The system must not authorize irreversible changes without explicit human consent and archival approval.
- Any on-site transport actions require signed authorization from the Head of Conservation or client representative.
Questions owners and crews ask
What is AI used for in tissue facing and temporary protection planning?
AI evaluates material compatibility, protection strategies, and sequencing, then proposes options while recording decisions for treatment proposals and condition reports.
How does AI interact with safety and COSHH procedures?
AI monitors sensor readings, flags hazardous conditions, and routes safety approvals to the qualified conservator before any action.
What documentation accompanies AI-driven plans?
Treatment proposals, condition reports, stock records, and transport records are generated and stored with the project archives.
Who approves AI-generated treatment plans?
An accredited conservator or designated safety officer signs off before execution and on-site work.